Bottom line
Is PEVAX a good fund? The bottom line
PEVAX is the Class A share class of PACE Small/Medium Co Value Equity Investments, an actively managed large value mutual fund from Pace Select Advisors.
Annual fees run 1.28% — about $128 a year on every $10,000 invested, more expensive than 82% of large value funds we track.
It returned +0.2% over one year, +6.5% a year over five years, +6.4% a year over ten (as of Dec 31, 2024, per its prospectus).
With $276 million in net assets and 189 holdings, its largest position is State Street Global Advisors (7.1%) and the top 10 make up 17.7% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.28%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What PEVAX invests in
Capital appreciation.
"Principal investments The fund invests primarily in stocks of companies that are believed to be undervalued or overlooked in the marketplace. These stocks also generally have price-to-earnings (""P/E"") ratios below the market average. Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in equity securities issued by small/medium capitalization companies. Small/medium capitalization companies means companies with a total market capitalization within the market capitalization range of the companies in the Russell 2500 ? Value Index at the time of purchase. The fund invests only in stocks that are traded on major exchanges or the over-the-counter market. The fund may from time to time invest a significant portion of its assets in the stocks of companies in various economic sectors, such as financials. The…
From the fund's prospectus (filed Nov 25, 2025).
PEVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PEVAX | +0.2% | +6.5% | +6.4% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2024
What PEVAX costs
On a $10,000 investment, PEVAX's 1.28% expense ratio costs about $128 a year. The prospectus estimates $2,010 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
PEVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | State Street Global Advisors | 7.11% |
| 2 | Jack Henry & Associates Inc | 1.50% |
| 3 | SLM Corp | 1.47% |
| 4 | Mohawk Industries Inc | 1.18% |
| 5 | WESCO International Inc | 1.18% |
| 6 | Jazz Pharmaceuticals PLC | 1.11% |
| 7 | First American Financial Corp | 1.11% |
| 8 | Avery Dennison Corp | 1.04% |
| 9 | Patterson-UTI Energy Inc | 1.04% |
| 10 | State Street Global Advisors | 0.96% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 17.7% of the fund. See all top 25 holdings and asset mix →